Molecular Features of Gastrointestinal Stromal Tumors: A Single Referral Cancer Center Experience

<h3>Background/Aim:</h3> Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the digestive tract. They frequently harbor mutations in KIT proto-oncogene, receptor tyrosine kinase (<i>KIT</i>) (70-80%) and platelet-derived growth factor receptor alpha (<i>PDGFRA</i>) (10-15%) genes, responding effectively to tyrosine kinase inhibitors (TKIs). Accurate genotyping is crucial for diagnosis and therapeutic management. This study reports a decade-long experience, detailing the epidemiological, pathological, and molecular characteristics of GISTs in a single-center cohort. <h3>Patients and Methods:</h3> Twenty-nine patients diagnosed with GIST (stomach, small bowel, colon, and peritoneum) at IRCCS CROB, Italy, between 2012 and 2021 were enrolled. Molecular analysis was performed using Sanger sequencing and Next-Generation Sequencing (NGS). <h3>Results:</h3> Twenty-three patients (85%) harbored <i>KIT</i> mutations, while four (15%) had <i>PDGFRA</i> mutations. Among <i>KIT</i>-mutated cases, five (22%) presented the p.Ala502_Tyr503dup duplication in exon 9. Elevated Ki-67 and a mitotic index of 3-7/50 high-power field (HPF) were associated with high recurrence risk. Eighteen patients (78%) exhibited mutations in exon 11: 8 (44%) were point mutations, 5 (28%) deletions, and 5 (28%) complex deletions. Point mutations at codons 557, 560, and 603 correlated with high recurrence risk, whereas mutations at codons 559 and 599 linked to low-risk disease. Most deletions and complex deletions showed high recurrence risk and Ki-67 &gt;10%. <i>PDGFRA</i> mutations were located in exon 18 (2 complex deletions, 2 point mutations including p.D842V); three of these cases showed low-to-moderate recurrence risk (Ki-67 ≤8%). <h3>Conclusion:</h3> This study characterizes the clinicopathological and molecular profiles of 29 Caucasian GIST patients, reinforcing the critical role of molecular stratification in clinical practice.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2026-05-27
DOI
https://doi.org/10.21873/anticanres.18180
Primary Topic
Gastrointestinal Tumor Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular Features of Gastrointestinal Stromal Tumors: A Single Referral Cancer Center Experience

Ludmila Carmen Omer, Angela Zupa, Giovanni Calice, Giulia Vita et al.
Anticancer Research
Gastrointestinal Tumor Research and Treatment
article

Molecular Features of Gastrointestinal Stromal Tumors: A Single Referral Cancer Center Experience

Ludmila Carmen Omer, Angela Zupa, Giovanni Calice, Giulia Vita, Giuseppina Improta, Alfredo Tartarone
article en

Abstract

<h3>Background/Aim:</h3> Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the digestive tract. They frequently harbor mutations in KIT proto-oncogene, receptor tyrosine kinase (<i>KIT</i>) (70-80%) and platelet-derived growth factor receptor alpha (<i>PDGFRA</i>) (10-15%) genes, responding effectively to tyrosine kinase inhibitors (TKIs). Accurate genotyping is crucial for diagnosis and therapeutic management. This study reports a decade-long experience, detailing the epidemiological, pathological, and molecular characteristics of GISTs in a single-center cohort. <h3>Patients and Methods:</h3> Twenty-nine patients diagnosed with GIST (stomach, small bowel, colon, and peritoneum) at IRCCS CROB, Italy, between 2012 and 2021 were enrolled. Molecular analysis was performed using Sanger sequencing and Next-Generation Sequencing (NGS). <h3>Results:</h3> Twenty-three patients (85%) harbored <i>KIT</i> mutations, while four (15%) had <i>PDGFRA</i> mutations. Among <i>KIT</i>-mutated cases, five (22%) presented the p.Ala502_Tyr503dup duplication in exon 9. Elevated Ki-67 and a mitotic index of 3-7/50 high-power field (HPF) were associated with high recurrence risk. Eighteen patients (78%) exhibited mutations in exon 11: 8 (44%) were point mutations, 5 (28%) deletions, and 5 (28%) complex deletions. Point mutations at codons 557, 560, and 603 correlated with high recurrence risk, whereas mutations at codons 559 and 599 linked to low-risk disease. Most deletions and complex deletions showed high recurrence risk and Ki-67 &gt;10%. <i>PDGFRA</i> mutations were located in exon 18 (2 complex deletions, 2 point mutations including p.D842V); three of these cases showed low-to-moderate recurrence risk (Ki-67 ≤8%). <h3>Conclusion:</h3> This study characterizes the clinicopathological and molecular profiles of 29 Caucasian GIST patients, reinforcing the critical role of molecular stratification in clinical practice.

Anticancer ResearchVol. 46(6)
Centro di Riferimento Oncologico della Basilicata (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Ministero della Salute
Good health and well-being
Openalex Percentile: Top 5%
Gastrointestinal Tumor Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.